⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S3 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

Christine Pich-Bavastro Laura Yerly Jérémy Di Domizio Stéphanie Tissot-Renaud Michel Gilliet François Kuonen

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S3: Immunosuppressive TME2 are enriched in ECM-remodeling CAFs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pich-Bavastro et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db64358752266b https://doi.org/10.1158/1078-0432.27032305

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
2Supplementary Figure S7 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
3Supplementary Figure S7 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
4Supplementary Figure S5 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
5Supplementary Figure S5 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
6Supplementary Figure S11 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
7Supplementary Figure S11 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024
8Supplementary Figure S6 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer2024